Blockchain Registration Transaction Record

GeoVax to Host Conference Call for First Quarter 2025 Financial Results

GeoVax Labs, Inc. announces conference call to discuss first quarter 2025 financial results and corporate update. Learn about the clinical-stage biotechnology company's innovative vaccines and therapies for COVID-19 and cancer.

GeoVax to Host Conference Call for First Quarter 2025 Financial Results

This news highlights GeoVax Labs, Inc.'s ongoing efforts in developing innovative vaccines and therapies for critical health issues such as COVID-19 and cancer. The live conference call offers investors and stakeholders an opportunity to gain insights into the company's financial performance and strategic direction, showcasing GeoVax's commitment to advancing healthcare solutions.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xf4f0c1bf24a4edaba4fd5cdcf6ebd16a687a103cea1308e22be926ff70da4709
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintzestYvTy-8f8655f3ff9fc84a2465a483d5ba1065